Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Active, Not Recruiting

Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer

NCT03368729

Conditions
Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Chicago Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Montefiore The Bronx, New York, United States
View Trial Details
Active, Not Recruiting

Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC

NCT04448886

Conditions
Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +7 more
Locations
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • DFCI @ Foxborough Foxborough, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Olaparib In Metastatic Breast Cancer

NCT03344965

Conditions
ATM Gene Mutation, BRIP1 Gene Mutation, Breast Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Indiana University Indianapolis, Indiana, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

NCT02051218

Conditions
Bone Metastases, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • Landeskrankenhaus Feldkirch Feldkirch, Austria
  • Klinikum Wels-Grieskrichen GmbH Wels, Austria
  • Uniklinik Düsseldorf, Urologische Klinik Düsseldorf, Germany
  • Universitätsklinikum Düsseldorf, Frauenheilkunde/Geburtshilfe Düsseldorf, Germany
View all 50 locations
View Trial Details
Active, Not Recruiting

A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer

NCT04556773

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +5 more
Locations
  • Research Site Commack, New York, United States
  • Research Site Harrison, New York, United States
  • Research Site New York, United States
  • Research Site New York, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer

NCT04538742

Conditions
Brain Diseases, Brain Neoplasms, Breast Diseases, +10 more
Locations
  • Research Site Fort Myers, Florida, United States
  • Research Site St. Petersburg, Florida, United States
  • Research Site Commack, New York, United States
  • Research Site Harrison, New York, United States
View all 72 locations
View Trial Details
Active, Not Recruiting

Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer

NCT05090358

Conditions
Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +6 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited protocol activity) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Palbociclib After CDK and Endocrine Therapy (PACE)

NCT03147287

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • University of Miami Miami, Florida, United States
  • Emory University - Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Indiana University Indianapolis, Indiana, United States
View all 22 locations
View Trial Details

Related conditions